Open original FDA record ↗Recall record
- FDA identifier
- Z-2833-2011
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Jul 15, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Boston Scientific is initiating an important field correction related to WALLSTENT", WALLSTENT" RP, and WALLGRAFT Tracheobronchial Endoprosthesis products. This letter is intended to clarify and re-emphasize that U.S. WALLSTENT", WALLSTENT" RP, and WALLGRAFT Tracheobronchial Endoprosthesis stents are NOT currently cleared by the FDA for use in benign tracheobronchial strictures.
Source facts
- Action
- The firm, Boston Scientific, sent an "Urgent Medical Device Field Correction" letter dated May 25, 2011 to its customers. The letter described the product, the problem and actions to be taken. The letter states that no product is being recalled and asks consignees not to return the product. The customers were instructed to read the enclosed information and post it in a way to ensure it is easily accessible to all users of this device; complete and return the Reply Verification Tracking Form via fax to: CV Field Action Center, 1-866-213-1806, and if they are a distributors to forward this notification to their customers. If you have any questions or would like assistance with this field correction, please contact your local Sales Representative and/or call 763-494-1133.
- Initiated
- 2011-05-25
- Root cause
- Labeling False and Misleading
- Terminated
- 2012-08-10
- Distribution
- Worldwide distribution.
- Recall number
- Z-2833-2011
- Recall status
- Terminated
- CDRH record ID
- 101125
- FDA classified
- 2011-07-15
- Recall event number
- 59096